Arteris (AIP) CEO Janac gets 78,051 RSUs and gifts 70,000 shares

Rhea-AI Filing Summary

Arteris, Inc. director and President and CEO K. Charles Janac reported multiple equity movements involving the company’s common stock. On February 18, 2026, he acquired 78,051 shares through a grant of restricted stock units, at a stated price of $0.0000 per share.

According to the footnotes, each RSU represents one share of common stock and will vest as to 1/16 of the total on April 1, 2026, then in equal quarterly installments thereafter, with no expiration date. After this grant, his directly held common stock position was 217,538 shares.

On February 20, 2026, Bayview Legacy, LLC, an entity for which Janac serves as manager with voting and dispositive power, made a bona fide gift of 70,000 common shares at a reported price of $0.0000 per share, leaving 9,279,071 shares indirectly held through that LLC. A separate line item shows 56,252 shares held indirectly by the Charles and Lydia Janac Trust, for which he serves as trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A(1)		78,051	A	$0.00	217,538	D
Common Stock	02/20/2026		G		70,000	D	$0.00	9,279,071	I	Bayview Legacy, LLC(2)
Common Stock								56,252	I	Charles and Lydia Janac Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 78,051 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2026 and in equal quarterly installments thereafter. The RSUs have no expiration date.

2. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

3. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity transactions did Arteris (AIP) CEO K. Charles Janac report?

K. Charles Janac reported a grant of 78,051 restricted stock units on February 18, 2026, and a bona fide gift of 70,000 common shares via Bayview Legacy, LLC on February 20, 2026, along with updated indirect trust holdings.

How many Arteris (AIP) shares were granted to the CEO in this Form 4?

The CEO received a grant of 78,051 restricted stock units, each representing one share of Arteris common stock. These RSUs vest 1/16 on April 1, 2026, with the remainder vesting in equal quarterly installments thereafter, and they have no expiration date.

What is the vesting schedule of the 78,051 RSUs granted to the Arteris (AIP) CEO?

The 78,051 RSUs vest with respect to 1/16 of the total on April 1, 2026. The remaining units vest in equal quarterly installments after that date, and the RSUs do not have an expiration date, according to the footnote disclosure.

What gift of Arteris (AIP) shares was reported through Bayview Legacy, LLC?

Bayview Legacy, LLC made a bona fide gift of 70,000 shares of Arteris common stock on February 20, 2026. K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over shares it beneficially owns.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the reported gift?

Following the bona fide gift of 70,000 shares, Bayview Legacy, LLC is shown holding 9,279,071 Arteris common shares. The Form 4 indicates that K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares.

What Arteris (AIP) shares are held through the Charles and Lydia Janac Trust?

The filing reports 56,252 Arteris common shares held indirectly by the Charles and Lydia Janac Trust. The footnotes state that K. Charles Janac serves as trustee of this trust, which explains his indirect beneficial ownership of those shares.